Ken Griffin Takeda Pharmaceutical CO LTD Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 1,695,400 shares of TAK stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,695,400

Previous 864,200 96.18%

Holding current value

$22.5 Million

Previous $11.2 Million 115.44%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.6 - $13.67 $3.82 Million - $4.14 Million	302,886 Added 3294.03%	312,081 $4.04 Million
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $1.2 Million - $1.3 Million	-86,564 Reduced 90.4%	9,195 $127,000
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $1.23 Million - $1.42 Million	92,068 Added 2494.39%	95,759 $1.37 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $670,097 - $727,610	-44,584 Reduced 92.35%	3,691 $57,000
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $120,527 - $132,448	-7,741 Reduced 13.82%	48,275 $758,000
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $554,251 - $597,779	36,273 Added 183.73%	56,016 $923,000
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $8.42 Million - $10.6 Million	-678,082 Reduced 97.17%	19,743 $308,000
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $3.79 Million - $8.48 Million	296,059 Added 73.69%	697,825 $9.05 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $762,048 - $872,987	58,083 Added 16.9%	401,766 $5.64 Million
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $248,255 - $281,442	-18,335 Reduced 5.06%	343,683 $4.92 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $499,933 - $622,544	-37,960 Reduced 9.49%	362,018 $4.93 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $1.24 Million - $1.32 Million	76,288 Added 23.57%	399,978 $6.55 Million
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $1.83 Million - $2.06 Million	110,412 Added 51.77%	323,690 $5.45 Million
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $2.34 Million - $2.79 Million	-140,122 Reduced 39.65%	213,278 $3.9 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $3.56 Million - $4.39 Million	231,403 Added 189.68%	353,400 $6.43 Million
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $263,237 - $295,410	15,394 Added 14.44%	121,997 $2.18 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $1.44 Million - $1.92 Million	-98,434 Reduced 48.01%	106,603 $1.91 Million
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $1.41 Million - $2.2 Million	108,154 Added 111.63%	205,037 $3.11 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $1.66 Million - $2.05 Million	-98,211 Reduced 50.34%	96,883 $1.91 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $416,476 - $463,926	25,788 Added 15.23%	195,094 $3.36 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $2.01 Million - $2.48 Million	121,028 Added 250.69%	169,306 $3 Million
Q1 2019 May 15, 2019	SELL	$16.7 - $21.52 $8.83 Million - $11.4 Million	-528,806 Reduced 91.63%	48,278 $0
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $9.03 Million - $12.2 Million	577,084 New	577,084 $9.71 Million

Others Institutions Holding TAK

# of Institutions

339

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account